Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study
Open Access
- 8 January 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (1)
Abstract
Introduction: Data on the impact of a heart failure hospitalization (HFH) on outcome in patients with transthyretin cardiac amyloidosis (TTR-CA) are scarce, although it remains a frequent adverse event. To assess the characteristics of patients with HFH in a real-world TTR-CA population, the occurrence of HFH, and the prognosis thereafter. Methods: Data were collected from a multicentre TTR-CA registry and patients were dichotomized according to the occurrence of at least one HFH. Landmark analysis at the 1-year follow-up and Cox regression analysis with HFH as a time-dependent covariate were performed to assess the impact of HFH on all-cause mortality. Results: Overall, 654 patients were included [median age 78 (64, 83) years, 70.5% male, 70.6% wild type]. During a median follow-up of 24 (11–45) months, 141 (22%) patients experienced at least one HFH and 170 (26%) patients died. Patients with a HFH were older (82 vs 76 years, P < .001), had more wild-type TTR-CA [126 (89.4%) vs 336 (65.5%), P < .001], were more symptomatic [New York Heart Association Class II–IV 119 (86.9%) vs 279 (62%), P < .001], had higher National Amyloidosis Centre (NAC) disease stage, were less treated with disease-modifying therapy [45 (31.9%) vs 247 (47.4%), P = .001], had more co-morbidities and showed signs of more advanced disease by echocardiography. At the 1-year time point, patients with HFH had significant worse overall survival (log-rank χ² 37.673, P < .001). At the univariable (HR 7.71, 95%CI 5.50, 10.82; P < .001) and multivariable analyses, HFH was associated with all-cause mortality and showed incremental value on top of clinical variables, biomarkers [estimated glomerular filtration rate in Model 1 (χ² 97.3; P < .001) and NAC disease stage in Model 2 (χ² 78.8; P < .001)] and echocardiographic parameters (left ventricular mass index + stroke volume index + significant valvular lesion in Model 3 (χ² 60.3; P < .001) and including E/e′ in Model 4 (χ² 43.4; P < .001)). Conclusion: HFH is independently associated with all-cause mortality in patients with TTR-CA and has incremental value on top of established risk models.Keywords
This publication has 35 references indexed in Scilit:
- Prevalence and Characteristics of Transthyretin Amyloid Cardiomyopathy in Hypertrophic CardiomyopathyESC Heart Failure, 2024
- The Diagnostic and Therapeutic Implications of Phenocopies and Mimics of Hypertrophic CardiomyopathyCanadian Journal of Cardiology, 2024
- Incidence and Predictors of Worsening Heart Failure in Patients with Wild-Type Transthyretin Cardiac AmyloidosisESC Heart Failure, 2022
- Natural History and Progression of Transthyretin Amyloid Cardiomyopathy: Insights from ATTR-ACTESC Heart Failure, 2021
- Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2021
- Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseasesEuropean Journal of Heart Failure, 2021
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2016
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- Pathophysiologic Targets in the Early Phase of Acute Heart Failure SyndromesThe American Journal of Cardiology, 2005
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986